mTOR inhibition as an adjuvant therapy in a metastatic model of HPV+ HNSCC

Effective treatments for recurrent/metastatic human papillomavirus-positive (HPV+) head and neck squamous cell cancer (HNSCC) are limited. To aid treatment development, we characterized a novel murine model of recurrent/metastatic HPV+ HNSCC. Further analysis of the parental tumor cell line and its...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Oncotarget
Main Authors: Coppock, Joseph D., Vermeer, Paola D., Vermeer, Daniel W., Lee, Kimberly M., Miskimins, W. Keith, Spanos, William C., Lee, John H.
Formato: Artigo
Idioma:Inglês
Publicado em: Impact Journals LLC 2016
Assuntos:
Research Paper
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5029697/
https://ncbi.nlm.nih.gov/pubmed/27015118
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.8286
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados